相关实验视频
Updated: Sep 18, 2025

08:26
Assessing Activity-based Anorexia in Mice
Published on: May 14, 2018
12.6K
低体重患者与神经性厌食症的药物治疗考虑:叙述性审查
William J Hayes1, McCall Stegenga2, John A Kappes3
1College of Pharmacy and Allied Health Professions, South Dakota State University, Rapid City, SD, 57702, USA. william.hayes@sdstate.edu.
Clinical drug investigation
|June 24, 2025
概括
神经性厌食症改变了药物处理,需要对伴随性疾病进行仔细的药物审查. 这篇评论强调了风险,就像布洛普一样,并敦促进行更多的研究,以获得更安全的厌食症神经性药物治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 营养科学 营养科学
背景情况:
- 神经性厌食症 (AN) 通常具有慢性过程,许多患者无法完全康复.
- 在AN中,营养不良,低体重和缓解症显著改变药物的药理动力学.
- 在AN中管理伴随性疾病需要仔细考虑药物治疗.
研究的目的:
- 探索营养不良神经性厌食症的体重不足患者的并发症的药物治疗策略.
- 检查体重不足的AN患者的药理动力学变化.
- 评估同时进行药物治疗的器官系统影响和影响.
主要方法:
- 综合文献搜索 (1969-2024年) 包括同行评审的研究,专家评论和灰色文献.
- 包括的研究重点是针对体重不足的AN患者的药物治疗考虑,但不包括仅接受治疗的研究.
- 分析了来自651个记录的14篇文章,这些文章符合包含标准.
主要成果:
- 证据有限,但文献强调了体重不足的AN患者的器官系统并发症.
- 基于受影响的器官系统,提供了药物考虑.
- 确定了与某些药物相关的特定风险,例如布洛普.
结论:
- 在神经性厌食症的并发症条件的药物治疗需要仔细考虑,因为改变了药理动力学.
- 器官系统并发症在AN影响药物的安全性和有效性.
- 进一步的研究对于开发改进的管理策略和确保患者安全至关重要.
相关概念视频
Anorexia Nervosa
210
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
210
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
Bulimia Nervosa
204
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
204
Psychosis: Goals of Pharmacotherapy
214
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
214
Antidepressant Drugs: MAOIs and Other Agents
378
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
378
Drug Abuse and Addiction: Pharmacological Phenomena
663
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
663

